Kodiak Sciences (KOD) Assets (2017 - 2026)
Kodiak Sciences' (KOD) quarterly Assets came in at $306.0 million in Q1 2026, up 2.72% YoY from $297.9 million in Q1 2025, and down 12.95% on a QoQ basis from $351.5 million in Q4 2025.
Kodiak Sciences (KOD) Assets (2017 - 2026) Analysis & Trends
Kodiak Sciences (KOD) has 10 years of Assets data on file, last reported at $306.0 million in Q1 2026.
- Quarterly Assets rose 2.72% year-over-year to $306.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $306.0 million (up 2.72% YoY) and the FY2025 annual result came in at $351.5 million, up 4.75% from the prior year.
- Assets declined to $306.0 million in Q1 2026, from $351.5 million in the prior quarter.
- In the past five years, Assets ranged from a high of $850.3 million in Q1 2022 to a low of $218.1 million in Q3 2025.
- A 5-year average of $485.6 million and a median of $434.8 million in 2024 frame the typical range for Assets.
- The widest YoY moves for Assets: up 4.75% in 2025, down 41.48% in 2025.
- Tracing KOD's Assets over 5 years: stood at $666.6 million in 2022, then retreated by 28.09% to $479.4 million in 2023, then decreased by 30.0% to $335.6 million in 2024, then advanced by 4.75% to $351.5 million in 2025, then dropped by 12.95% to $306.0 million in 2026.
- The last three Assets figures came in at $306.0 million (Q1 2026), $351.5 million (Q4 2025), and $218.1 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 27.42 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 41.73 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 10.03 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 4.32 Bn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 9.18 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 15.59 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 19.82 Bn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 5.56 Bn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 2.10 Bn |
| 10 | Kodiak Sciences | 2.60 Bn | 2.60 Bn | - | 256.81 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 256.81 Mn |
| Mar 31, 2026 | 306.01 Mn |
| Dec 31, 2025 | 351.53 Mn |
| Sep 30, 2025 | 218.07 Mn |
| Jun 30, 2025 | 256.73 Mn |
| Mar 31, 2025 | 297.91 Mn |
| Dec 31, 2024 | 335.58 Mn |
| Sep 30, 2024 | 372.67 Mn |
| Jun 30, 2024 | 401.58 Mn |
| Mar 31, 2024 | 434.76 Mn |
| Dec 31, 2023 | 479.37 Mn |
| Sep 30, 2023 | 547.65 Mn |
| Jun 30, 2023 | 589.66 Mn |
| Mar 31, 2023 | 640.33 Mn |
| Dec 31, 2022 | 666.63 Mn |
| Sep 30, 2022 | 723.99 Mn |
| Jun 30, 2022 | 781.91 Mn |
| Mar 31, 2022 | 850.29 Mn |
| Dec 31, 2021 | 904.22 Mn |
| Sep 30, 2021 | 958.21 Mn |